{
    "2020-06-05": [
        [
            {
                "time": "2021-03-15",
                "original_text": "Donâ€™t Judge Pfizer by Its Vaccine Efforts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Vaccine",
                        "Efforts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Coronavirus update: Payrolls spark hope for a fast rebound as Novavax gets a boost in vaccine race",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Payrolls",
                        "Novavax",
                        "vaccine",
                        "rebound"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "LLY",
                        "Coronavirus",
                        "Antibody",
                        "Phase I",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}